Research Article

Pola penggunaan insulin pada pasien diabetes mellitus tipe 2 di poli penyakit dalam RSU Negara Periode Juli – Agustus 2018

Komang ayu Vitriana Gamayanti , Ni Luh Made Novi Ratnasari, Agha Bhargah

Komang ayu Vitriana Gamayanti
Departemen Ilmu Penyakit Dalam, Rumah Sakit Umum Negara, Jembrana. Email: vitrianagamayanti@gmail.com

Ni Luh Made Novi Ratnasari
Faculty of Medicine, Udayana University, Sanglah Hospital, Bali

Agha Bhargah
Faculty of Medicine, Udayana University, Sanglah Hospital, Bali
Online First: December 15, 2018 | Cite this Article
Gamayanti, K., Ratnasari, N., Bhargah, A. 2018. Pola penggunaan insulin pada pasien diabetes mellitus tipe 2 di poli penyakit dalam RSU Negara Periode Juli – Agustus 2018. Intisari Sains Medis 9(3). DOI:10.15562/ism.v9i3.306


Aim: This study aims to determine the pattern of insulin therapy in type 2 Diabetes Mellitus patient in Internal Medicine Policlinic Negara Hospital, Bali.

Method: This research was an observational study with cross-sectional design at Internal Medicine Policlinic Negara Hospital, Bali period August 2018. A total of 177 samples were selected by total sampling technique.

Result: According to the duration of action, majority of insulin usage was rapid acting insulin in 93 patients (52,5%). The most frequent combination of two insulin types was long-acting with rapid-acting insulin in 30 patients (33,7%), meanwhile the  most frequent combination of insulin and OHD was premixed insulin with gluconeogenesis inhibitor in 43 patients (48,9%). Fasting Plasma Glucose mean was 185,12 mg/dL, Post Prandial Plasma Glucose mean was 252,9 mg/dL. This study also found the Fasting Plasma Glucose ≥ 126 mg/dL count in 129 patients (72,9%), Post Prandial Plasma Glucose ≥ 180 mg/dl count in 133 patients (75,1%). The mean of systolic blood pressure was 128,81/ 78,53 mmHg, patients with targeted blood pressure <140/90 mm/Hg count in 110 patients (62,1%).

Conclusion: The profile of insulin therapy in patients with Type 2 DM at Internal Medicine Polyclinic, Negara Hospital varies according to the indication in each patient. The most frequent type of insulin use is rapid acting insulin. Most patients with insulin therapy have not achieved targeted glycemic control, but have achieved the targeted blood pressure according to the PERKENI.

References

Ogurtsova K, Fernandes JDD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF Diabetes Atlas : Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Research and Clinical Practice. 2017;128:40-50

Kemenkes RI. Riset kesehatan dasar dalam angka riskesdas 2013 provinsi Bali. Jakarta: Kemenkes RI; 2013

Kemenkes RI. Laporan hasil riset kesehatan dasar (Riskesdas) Indonesia tahun 2013. Jakarta: Kemenkes RI; 2013

Tsai ST, Pathan F, Ji L, Yeung VTF, Chadha M, Suastika K, et al. First insulinization with basal insulin in patients with Type 2 diabetes in a real-world setting in Asia. J of Diabetes. 2011;3:208–216

PB PERKENI. Konsensus pengelolaan dan pencegahan diabetes melitus tipe 2 di Indonesia. Jakarta: PB PERKENI; 2015

Akbar MF, Ilmi YH. The use of insulin for early diagnosed patients with type 2 diabetes mellitus in primary health care in Indonesia: a general practitioner’s perspective. J Med Allied Sci. 2017;7(1):72-7.

Pranoto A, Novida H, Prajitno JH, Tjokroprawiro A. Safety and efficacy in early insulin initiation as comprehensive therapy for patients with type 2 diabetes in primary health care centers. Acta Med Indones. 2015 Apr;47(2):104-10

Inayah, Hamidy MY, Yuki RPR. Pola penggunaan insulin pada pasien diabetes melitus tipe 2 rawat inap di Rumah Sakit X Pekanbaru tahun 2014. JIK. 2016 March;10(1):38-43

Andayani TM, Ibrahim MIM, Asdie AH. Comparison of the glycemic control of insulin and triple oral therapy in type 2 diabetes mellitus. J Diabetes Endocrinol. 2010 Apr;1(2):13-8

Baruah MP, Kalra S, Bose S, Deka J. An audit of insulin usage and insulin injection practices in a large Indian cohort. Indian J Endocr Metab. 2017;21:443-52

Tseng CH. Exogenous insulin use and hypertension in adult patients with type 2 diabetes mellitus. Arch Intern Med. 2006 Jun;166:1184-9

Feliasari A. Profil penderita diabetes melitus tipe 2 dengan terapi insulin di poli rawat jalan RSUD Dr. Soedarso Pontianak [skripsi]. Pontianak: Universitas Tanjungpura; 2014

Suastika K, Dwipayana P, Semadi MS, Kuswardhani RAT. Age is an important risk factor for type 2 diabetes mellitus and cardiovascular diseases. 2012. IntechOpen, DOI: 10.5772/52397. Available from: https://www.intechopen.com/books/glucose-tolerance/age-is-an-important-risk-factor-for-type-2-diabetes-mellitus-and-cardiovascular-diseases

Yulianti SR, Mukaddas A, Faustine I. Profil pengobatan pasien diabetes melitus tipe 2 di instalasi rawat inap RSUD undata palu tahun 2012. Online jurnal of natural science. 2014 March;3(1):40-6

American Diabetes Association. 8. Pharmacologic approaches to glycemic treatment: Standards of Medical Care in Diabetes. Diabetes Care. 2018;41(Suppl. 1): S73–S85

Giugliano D, Maiorino MI, Bellastella G, Chiodini P, Ceriello A, Esposito K. Efficacy of insulin analogs in achieving the hemoglobin A1c target of 7% in type 2 diabetes: meta-analysis of randomized controlled trials. Diabetes Care. 2011;34:510-7

Mosenzon O, Raz I. Intensification of insulin therapy for type 2 diabetic patients in primary care: basal-bolus regimen versus premix insulin analogs when and for whom?. Diabetes Care. 2013;36(Suppl. 2):S212-S218

Boer IH, Bangalore S, Benetos A, Davis AM, Michos ED, Muntner P, Rossing P, et al. Diabetes and hypertension: a position statement by the American Diabetes Association. Diabetes Care. 2017;40:1273–1284.


No Supplementary Material available for this article.
Article Views      : 76
PDF Downloads : 46